Articles from QT Imaging Holdings, Inc.
QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time
QT Imaging Holdings, Inc. (NASDAQQTI) (“QTI”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe.
By QT Imaging Holdings, Inc. · Via Business Wire · January 14, 2025
QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth
QT Imaging Holdings, Inc. (NASDAQQTI) (the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026.
By QT Imaging Holdings, Inc. · Via Business Wire · January 13, 2025
QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc.
By QT Imaging Holdings, Inc. · Via Business Wire · December 12, 2024
QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation at the Radiological Society of North America 2024 Annual Meeting, taking place in Chicago, December 1-5, 2024. Dr. Bilal Malik, Chief Science Officer, Dr. James Wiskin, Fellow, and Dr. Raluca Dinu, Chief Executive Officer, will represent QTI at the event.
By QT Imaging Holdings, Inc. · Via Business Wire · November 21, 2024
QT Imaging Announces Third Quarter 2024 Financial Results
QT Imaging Holdings, Inc. (NASDAQQTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the third quarter of 2024.
By QT Imaging Holdings, Inc. · Via Business Wire · November 13, 2024
QT Imaging Holdings Announces $1M Insiders PIPE Investment
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems (the “Company” or “QTI”) is pleased to announce an insiders private investment in public equities (PIPE) investment of $1.0 million in new funding, led by the Chairman of the Board, Dr. Avi Katz, and the Chief Executive Officer, Dr. Raluca Dinu, with participation of an additional four QTI Board of Directors members (the “Investors”). In addition, one existing creditor of the Company managed by Dr. Katz, GigAcquisitions5, LLC, agreed to surrender to the Company and cancel a promissory note that it holds with a principal amount of $1.56 million as an additional Investor. Under the terms of the securities purchase agreement entered into today, the Investors agreed to purchase 4,383,558 unregistered shares of common stock of QTI at a price of $0.584 per share, together with 4,383,558 warrants with an exercise price of $0.672 per share. The price per share represents a premium of approximately 10% to QTI common stock’s volume weighted average trading price over the last 5 days prior to today’s investment. The closing of the financing is anticipated to be on or before November 29, 2024, and it was placed directly by QTI, thus it included no associated banking fees. The proceeds are aimed solely at providing working capital for the Company as sufficient bridge funding while it continues to pursue its agreements with its previously announced strategic partner, and it successfully executes on its commercialization growth plan.
By QT Imaging Holdings, Inc. · Via Business Wire · November 13, 2024
QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the National Institutes of Health (NIH)/National Cancer Institute (NCI). The study is a collaboration with the Department of Radiation Oncology, the Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada, the largest cancer center in Canada, and The University of Illinois, Urbana-Champaign, Department of Electrical and Computer Engineering and Grainger College of Engineering.
By QT Imaging Holdings, Inc. · Via Business Wire · October 29, 2024
QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note
QT Imaging Holdings, Inc. (NASDAQQTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce an amendment to its $10,000,000 convertible promissory note with YA II PN, Ltd. (the “Investor,” and such promissory note, the “Note”).
By QT Imaging Holdings, Inc. · Via Business Wire · September 30, 2024
QT Imaging Holdings Announces Further Expansion of Locations Offering Its Technology at Vitality Renewal, in Illinois
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce further expansion of locations offering the Breast Acoustic CT™ Scanner to Vitality Renewal Functional Medicine, in Crystal Lake, Illinois. The commercial shipment was made together with our strategic business and distribution partner.
By QT Imaging Holdings, Inc. · Via Business Wire · August 27, 2024
QT Imaging Announces Second Quarter 2024 Financial Results
QT Imaging Holdings, Inc. (NASDAQQTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024.
By QT Imaging Holdings, Inc. · Via Business Wire · August 8, 2024
QT Imaging Holdings Announces Partnership with PerfeQTion Imaging Center in Haverford, Pennsylvania
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce our latest shipment of the Breast Acoustic CT™ Scanner to PerfeQTion Imaging Center in Haverford, Pennsylvania, together with our strategic business and distribution partner.
By QT Imaging Holdings, Inc. · Via Business Wire · July 24, 2024
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
By QT Imaging Holdings, Inc. · Via Business Wire · June 24, 2024
QT Imaging Announces First Quarter 2024 Financial Results
QT Imaging Holdings, Inc. (NASDAQQTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024.
By QT Imaging Holdings, Inc. · Via Business Wire · May 10, 2024
QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ
QT Imaging Holdings, Inc. (NASDAQQTI) (“QT Imaging”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with its strategic business and distribution partner, is proud to announce its partnership with The Vincere Cancer Center in Scottsdale, AZ.
By QT Imaging Holdings, Inc. · Via Business Wire · May 8, 2024
QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell
QT Imaging Holdings, Inc. (NASDAQQTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square.
By QT Imaging Holdings, Inc. · Via Business Wire · April 22, 2024
QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce positive data regarding the diagnostic performance of QTI’s Breast Acoustic CTTM Scans for mass detection from its second blinded multi-reader multi-case study. The study was published in Academic Radiology, online, in January 2024: A Multireader Multicase (MRMC) Receiver Operating Characteristic (ROC) Study Evaluating Noninferiority of Quantitative Transmission (QT) Ultrasound to Digital Breast Tomosynthesis (DBT) on Detection and Recall of Breast Lesions - Academic Radiology
By QT Imaging Holdings, Inc. · Via Business Wire · April 16, 2024
QT Imaging’s Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with our strategic business and distribution partner are proud to announce their partnership with the Center of New Medicine in Irvine, California. The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care including cancer prevention, its early detection, and internal medicine. With the incorporation of the QT Imaging Breast Acoustic CT™ Scanner, the Center for New Medicine will expand their innovative services in women’s and breast health.
By QT Imaging Holdings, Inc. · Via Business Wire · April 11, 2024
QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that the Board of Directors has appointed former GigCapital5, Inc. CEO Dr. Raluca Dinu as Active Chief Executive Officer and member of the Board of Directors, effective March 12, 2024. Dr. Dinu will serve in this position for one year, when the Company will reevaluate this strategic position. Dr. John Klock will step down as Chief Executive Officer, but will remain part of the Board of Directors, transitioning to serve as a Company advisor. As previously announced, Anastas (Stas) Budagov will take the position of Chief Financial Officer.
By QT Imaging Holdings, Inc. · Via Business Wire · March 18, 2024
QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units
QT Imaging Holdings, Inc. (NASDAQQTI), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter (OTC) market, effective as of March 11, 2024. The company’s units formerly trading in the OTC market under “GIAFU” have been delisted as of March 11, 2024, as each unit was split into one share of common stock and one warrant upon the closing of its business combination on March 4, 2024.
By QT Imaging Holdings, Inc. · Via Business Wire · March 15, 2024
QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the delivery of a Breast Acoustic CT™ Scanner under a unique collaboration with the Department of Radiation Oncology, and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada, one of the largest cancer centers in Canada, and The University of Illinois, Urbana-Champaign, Department of Electrical and Computer Engineering and Grainger College of Engineering. This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).
By QT Imaging Holdings, Inc. · Via Business Wire · March 14, 2024
QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership
QT Imaging Holdings, Inc. (NASDAQQTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the first commercial sale of a QTI Breast Acoustic CT™ System to True Health Center for Functional Medicine. QTI’s inaugural customer was born as a result of the collaboration with our previously announced strategic distribution partner and represents the business model to be deployed by the company.
By QT Imaging Holdings, Inc. · Via Business Wire · March 7, 2024